Free Float 69,53 %
Shares Float 11,38 M
Shares Outstanding 16,37 M
Roquefort Therapeutics plc (Delisted) Share · GB00BMDQ2T15 (XLON) United Kingdom · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
This security is no longer traded.
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Roquefort Therapeutics plc
No Price
Share Float & Liquidity
Company Profile for Roquefort Therapeutics plc Share
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Company Data
Name Roquefort Therapeutics plc
Company Roquefort Therapeutics plc
Website
https://www.roquefortinvest.com
Primary Exchange 
London
London
ISIN GB00BMDQ2T15
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Stephen Paul West CA
Country United Kingdom
Currency GBX
Employees 0,0 T
Address Eccleston Yards, SW1W 9NF London
IPO Date 2021-03-22
Stock Splits
| Date | Split |
|---|---|
| 27.03.2026 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | RTPLCR15.DUSB |
| Frankfurt | 0AG.F |
| London | ROQ.L |